More PRNewswire
View Older Stories View Newer Stories-
With a Two-Year Revenue Growth of 630.22%, InstaLend Corporation Ranks No. 22 on Inc. Magazine's List of the Northeast Region's Fastest-Growing Private Companies
-
Red Door Capital Partners increases their ownership in Adapt Ideations Global PTE LTD ("Adapt"), a technology company in global logistics, data intelligence and supply chain management.
-
MDO Becomes Otelier and Launches IntelliSight, a Unified Business Intelligence Platform
-
Ryght and Lucem Health partner to advance disease detection and treatment with AI technology
-
AgileBlue Automates SecOps and SOAR with Sapphire AI
-
VANCORD RECOGNIZED ON CRN's MSP 500 List
-
Zhongchao Inc. Announces 1-for-10 Share Consolidation
-
Kakao Brain Unveils Labeler Project Exclusively for Medical Image preliminary report
-
Hedia Raises €3M Seed Extension to Expand Digital Health Portfolio
-
NextEra Energy Capital Holdings announces offering of its Series Q junior subordinated debentures
-
NextEra Energy Capital Holdings announces offering of $900 million in aggregate principal amount of exchangeable senior notes due 2027
-
Record: 193 green tech start-ups grow in Austria
-
Huawei Launches a Wide Range of Net5.5G Solutions to Inspire New Growth of Carriers
-
Canaan Inc. Reports Unaudited Fourth Quarter and Full Year 2023 Financial Results
-
Tongyu Communication at MWC Barcelona 2024: Showcasing Latest Innovations That Drive Success in the Global Markets
-
Azalea Health Unveils Artificial Intelligence Strategy to Enhance Healthcare Workflows
-
Hard-Won Innovation Advice for Leaders Seeking to Catalyze Success
-
Jazz Pharmaceuticals Appoints Patrick Kennedy to its Board of Directors
-
Virtual Incision Receives FDA Authorization for the First Miniaturized Robotic-Assisted Surgery Device
-
U.S. MONEY RESERVE ISSUES FREE REPORT ON THE FUTURE OF GOLD
-
U.S. Food and Drug Administration (FDA) Grants Priority Review of Epcoritamab (EPKINLY®) for Difficult-to-Treat Relapsed or Refractory Follicular Lymphoma (FL)
-
FIBRA Prologis announces the launch of an offering of CBFIs
-
Renovus Capital Partners Announces the Successful Close of a $325 Million Continuation Fund to Support the Exit and Future Growth of Four Portfolio Companies
-
Announcing stand-alone, on-demand virtual lab platform
-
Mental Health and Recovery Redefined at Next Level Recovery Associates
-
FIBRA Prologis Lowers Management Fee Paid to Prologis going forward
-
Innovid Reports Q4 and Fiscal Year 2023 Financial Results
-
eHealth, Inc. Announces Fourth Quarter and Fiscal Year 2023 Results
-
Delek Logistics Reports Fourth Quarter 2023 Results and 2024 Capital Program
-
AIVITA Biomedical Strengthens Board of Directors with Appointment of Ex-Biogen CEO Michel Vounatsos
-
Reese Pharmaceutical Launches New At-Home Colon Cancer Screening Test
-
JLL Reports Financial Results for Fourth-Quarter and Full-Year 2023
-
ZSuite Tech Accelerates Access to Escrow Innovation for Financial Institutions Via AppMarket from Fiserv
-
Dream job alert: Professional Restaurant Visitor-- Get paid to dine out: Unmo
-
ETS and Study.com Partner to Break Down Barriers in National Educator Pipeline
-
MyFBAPrep Named to "Inc. 5000 Regionals: Southeast List" for Second-Consecutive Year
-
Say Goodbye to Bad Window Installations
-
Lithia & Driveway Expands in North Central Region with the Purchase of Carousel Motor Group
-
With a Two-Year Revenue Growth of 505%, Capital Rx Ranks No. 32 on Inc. Magazine's List of the Northeast Region's Fastest-Growing Private Companies
-
ONCOR REPORTS 2023 RESULTS; ANNOUNCES $24.2 BILLION 2024-2028 CAPITAL PLAN
-
Cyngn Announces Date for 2023 Fourth Quarter and Year-End Financial Results
-
Ginkgo Bioworks Announces Participation in the 44th Annual TD Cowen Health Care Conference
-
Silicon Labs Names Dean Butler as Chief Financial Officer
-
High 5 Plumbing celebrates successful graduates and participants of its apprenticeship program
-
Viking Therapeutics Announces Positive Top-Line Results from Phase 2 VENTURE Trial of Dual GLP-1/GIP Receptor Agonist VK2735 in Patients with Obesity
-
CAESARSTONE UNVEILS 'BEYOND THE SURFACE' REPORT EXPLORING THE IMPACTS OF DESIGN ON EVERYDAY LIFE
-
Top Rail Fence opens two new Florida locations with ribbon-cutting ceremony
-
Inspira™ To Host Conference Call to Discuss Investor Presentation and Announce Next Major Milestone
-
Acurx Announces FDA Has Granted an End of Phase 2 Meeting for Ibezapolstat for C. difficile Infection and the European Medicines Agency Granted SME Designation for Ibezapolstat EU Development
-
Inspira™ Announces Breakthrough Update: Nears First FDA 510(k) Approval, 3 U.S. Patents Approved, $546 million in Summary Distribution Agreements
